DIVY

SYDNEY: Neuren Pharmaceuticals, the $1.5bn ASX-listed biotech company that for a few loyal ... read more

SINGAPORE: Aegros has partnered with Cambodia’s Royal Group to build a $US400m ($615m) ... read more

MELBOURNE: David Di Pilla’s HMC Capital is understood to have explored an investment ... read more